Delivery Order SPE2DB24D1205-SPE2DB25FCZMH
Award Date 8/13/25
Potential Completion Date 9/4/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,110.80 to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a prescription oncology medication used in cancer treatment. This firm fixed-price delivery order, issued on September 5, 2025, with completion targeted for September 26, 2025, represents a non-competitive award under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania. This award...
- The Defense Logistics Agency awarded a $17,777 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a oncology therapeutic agent used in cancer treatment. The contract was competitively awarded without set-aside restrictions and carries an ultimate completion date of September 24, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,443.90 for 100 mg vials of Enhertu, a oncology therapeutic agent, with performance in Conshohocken, Pennsylvania and completion scheduled for May 13, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order executes...
- The Defense Logistics Agency awarded a $8,888.50 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a therapeutic oncology medication, with an ultimate completion date of September 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The...
- The Defense Logistics Agency awarded a $14,221.60 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a specialized oncology medication, with performance at the contractor's Conshohocken, Pennsylvania location. The contract is structured as a firm fixed-price delivery order under a non-competitive set-aside, with an ultimate completion date of October 3, 2025. This award represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Enhertu 100 mg vials, valued at $17,777.00, with a completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Enhertu 100 mg vials, a specialized oncology medication. This firm fixed-price delivery order, valued at $5,333.10, represents a non-set-aside competitive award with performance scheduled through June 24, 2025. The award will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency awarded a $17,777.00 delivery order to AmerisourceBergen Drug Corp for 100 milligram vials of Enhertu, a specialty oncology medication. This firm fixed price contract, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements with the federal government. The award was competitively granted without set-aside provisions and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $17,777.00 to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a cancer therapeutic agent. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Enhertu 100 mg vials, a specialized oncology medication. This competitively awarded, non-set-aside delivery order carries a firm fixed price ceiling value of $10,666.20 and is scheduled for completion by August 13, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...